Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LAMOTRIGINE Cause Transaminases increased? 184 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 184 reports of Transaminases increased have been filed in association with LAMOTRIGINE (Lamotrigine ER). This represents 0.4% of all adverse event reports for LAMOTRIGINE.

184
Reports of Transaminases increased with LAMOTRIGINE
0.4%
of all LAMOTRIGINE reports
2
Deaths
128
Hospitalizations

How Dangerous Is Transaminases increased From LAMOTRIGINE?

Of the 184 reports, 2 (1.1%) resulted in death, 128 (69.6%) required hospitalization, and 37 (20.1%) were considered life-threatening.

Is Transaminases increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LAMOTRIGINE. However, 184 reports have been filed with the FAERS database.

What Other Side Effects Does LAMOTRIGINE Cause?

Drug ineffective (5,175) Seizure (3,459) Toxicity to various agents (3,256) Rash (3,249) Foetal exposure during pregnancy (2,985) Off label use (2,625) Completed suicide (2,433) Drug reaction with eosinophilia and systemic symptoms (2,235) Dizziness (2,170) Pyrexia (1,967)

What Other Drugs Cause Transaminases increased?

METHOTREXATE (1,236) ACETAMINOPHEN (929) ATORVASTATIN (472) RITUXIMAB (448) CYCLOPHOSPHAMIDE (401) PREDNISONE (362) ADALIMUMAB (340) PACLITAXEL (333) ROSUVASTATIN (324) CARBOPLATIN (319)

Which LAMOTRIGINE Alternatives Have Lower Transaminases increased Risk?

LAMOTRIGINE vs LANADELUMAB LAMOTRIGINE vs LANADELUMAB-FLYO LAMOTRIGINE vs LANREOTIDE LAMOTRIGINE vs LANSOPRAZOLE LAMOTRIGINE vs LANTHANUM

Related Pages

LAMOTRIGINE Full Profile All Transaminases increased Reports All Drugs Causing Transaminases increased LAMOTRIGINE Demographics